| 标题 |
 Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：The Lancet Haematology 作者：Jacob D. Soumerai; Anthony R. Mato; Ahmet Doğan; Venkatraman Seshan; Erel Joffe; et al 出版日期：2021-11-24 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Criminology34
null
cdercder
Lo
DW
Enigma_GEB
Nole
无极微光
秋风
修仙中
DOC_XIONG
GingerF
Ali
七颗茶香豆
OK
song
学术文献互助
Kao
aaaa
CR7
皖公网安备34019202002308
